Optimizing Drug Delivery Systems for Enhanced Therapeutic Efficacy in Cancer Treatment: A Multidisciplinary Approach
Main Article Content
Abstract
This research aims to develop an early detection method for breast cancer through the analysis of specific biomarkers. The method leverages advanced drug delivery technology to enhance the efficacy of cancer therapy. Employing a multidisciplinary approach, this study integrates medical and pharmaceutical sciences to achieve optimal results. Specific biomarkers utilized in this research will be identified to improve the sensitivity and specificity of cancer detection. The findings of this research are anticipated to make a significant contribution to enhancing early breast cancer detection capabilities and optimizing therapy utilization in patients.
Article Details
References
Bertoli, G., Cava, C., & Castiglioni, I. (2015). MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics, 5(10), 1122.
Faden, D. L., & Algazi, A. (2017). Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. Journal of the National Cancer Institute, 109(1), djw190.
Ginsburg, O., Bray, F., Coleman, M. P., Vanderpuye, V., Eniu, A., Kotha, S. R., ... & Conteh, L. (2017). The global burden of women’s cancers: a grand challenge in global health. The Lancet, 389(10071), 847-860.
Hiatt, R. A., Haslam, S. Z., & Osuch, J. (2009). The breast cancer and the environment research centers: transdisciplinary research on the role of the environment in breast cancer etiology. Environmental health perspectives, 117(12), 1814-1822.
Kraut, R., Patterson, M., Lundmark, V., Kiesler, S., Mukophadhyay, T., & Scherlis, W. (1998). Internet paradox: A social technology that reduces social involvement and psychological well-being?. American psychologist, 53(9), 1017.
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K. A., Mooij, T. M., Roos-Blom, M. J., ... & BRCA1 and BRCA2 Cohort Consortium. (2017). Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Jama, 317(23), 2402-2416.
Ng, Z. X., Ong, M. S., Jegadeesan, T., Deng, S., & Yap, C. T. (2017, May). Breast cancer: exploring the facts and holistic needs during and beyond treatment. In Healthcare (Vol. 5, No. 2, p. 26). MDPI.
Sahoo, S. K., & Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging. Drug discovery today, 8(24), 1112-1120.
Seyhan, A. A. (2019). Lost in translation: the valley of death across preclinical and clinical divide–identification of problems and overcoming obstacles. Translational Medicine Communications, 4(1), 1-19.
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., ... & Børresen-Dale, A. L. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences, 98(19), 10869-10874.
Spoth, R., Rohrbach, L. A., Greenberg, M., Leaf, P., Brown, C. H., Fagan, A., ... & Society for Prevention Research Type 2 Translational Task Force Members and Contributing Authors. (2013). Addressing core challenges for the next generation of type 2 translation research and systems: The translation science to population impact (TSci Impact) framework. Prevention Science, 14, 319-351.
Starfield, B., Shi, L., & Macinko, J. (2005). Contribution of primary care to health systems and health. The milbank quarterly, 83(3), 457-502.
Tonetti, M. S., Greenwell, H., & Kornman, K. S. (2018). Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. Journal of periodontology, 89, S159-S172.
Triberti, S., Savioni, L., Sebri, V., & Pravettoni, G. (2019). eHealth for improving quality of life in breast cancer patients: a systematic review. Cancer treatment reviews, 74, 1-14.
Wang, L. (2017). Early diagnosis of breast cancer. Sensors, 17(7), 1572.
Wangmo, T., Lipps, M., Kressig, R. W., & Ienca, M. (2019). Ethical concerns with the use of intelligent assistive technology: findings from a qualitative study with professional stakeholders. BMC medical ethics, 20(1), 1-11.